Has Peter Hughes, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,265 in general payments to Peter Hughes, MD across 17 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Peter Hughes, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Peter Hughes, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Peter Hughes, MD

Orthopaedic Surgery · Stamford, CTNPI 1942399886

Payments from drug & device makers

$1,265in general payments, 2019–2025

Across 17 payments — averaging $74.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$767
Stryker$355
Si-bone, Inc.$94
Merck$20
Bioventus LLC$18
Tolmar Pharmaceuticals, Inc.$11

What the payments were for

Food & beverage$1,265100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	8	$767
Stryker	4	$355
Si-bone, Inc.	2	$94
Merck	1	$20
Bioventus LLC	1	$18
Tolmar Pharmaceuticals, Inc.	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,265 in reported general payments places this provider in the 35th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut →

Medicare billing

Part B allowed, 2024

$208,691

Medicare patients

335

Services billed

3,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Meloxicam	251	$500
Nabumetone	30	$268
Clindamycin Hcl	12	$246
Ibuprofen	17	$160
Methylprednisolone	19	$150
Gabapentin	27	$142
Tramadol Hcl	48	$135
Amoxicillin	27	$95
Oxycodone Hcl	30	$92
Cyclobenzaprine Hcl	17	$85

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Stamford

Jim HsuStamford$358K
Peter WhangNew Haven$2M
James YueShelton$1.8M
Paul SethiGreenwich$1.6M
Robert DeveneyDanbury$907K
Isaac MossFarmington$783K
James PaceFarmington$721K
John KeggiMiddlebury$380K
Sean EsmendeGlastonbury$363K
David FrumbergNew Haven$288K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →